Skip to search formSkip to main contentSkip to account menu

ING-1

Known as: monoclonal antibody ING-1 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Phase I and pharmacokinetic study of a subcutaneously administered human-engineered monoclonal antibody ING-1 in patients with advanced adenocarcinomas
2558 Background: ING-1 is a high-affinity, human-engineered monoclonal antibody that recognizes a 40 kD Epithelial Cell Adhesion… 
Review
2003
Review
2003
Technology evaluation: ING-1, XOMA.
  • L. Lewis
  • Current opinion in molecular therapeutics (Print)
  • 2003
  • Corpus ID: 27541692
XOMA is developing ING-1, a human engineered immunoglobulin G1 antibody, as a potential treatment for carcinoma and solid tumors… 
1991
1991
Chimeric mouse-human anti-carcinoma antibodies that mediate different anti-tumor cell biological activities.
Two chimeric mouse-human antibodies, ING-1 (IgG1, kappa) and ING-2 (IgG1, lambda), have been constructed starting from… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)